Kraig Biocraft Laboratories, Inc. (KBLB)
| Market Cap | 58.73M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -6.44M |
| Shares Out | 978.78M |
| EPS (ttm) | -0.01 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 61,455 |
| Open | 0.0575 |
| Previous Close | 0.0575 |
| Day's Range | 0.0575 - 0.0600 |
| 52-Week Range | 0.0500 - 0.1200 |
| Beta | 0.05 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 10, 2022 |
About KBLB
Kraig Biocraft Laboratories, Inc. engages in developing protein-based fibers using recombinant DNA technology for commercial applications in the technical textile and specialty fiber industries in the United States. The company's products are used in military and police applications for ballistic protection; industrial applications, including critical cables and abrasion/impact resistant components; safety equipment; and composite materials for the aero-space industry. Its products are also used in various markets, such as medical textiles, geo... [Read more...]
News
Kraig Biocraft Laboratories Posts Behind the Scenes Look into the Laboratory R&D Processes for Creating Recombinant S...
ANN ARBOR, Mich., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), the biotechnology company focused on the development and commercializatio...
Kraig Biocraft Laboratories Apparel Brand SpydaSilk™ Attends Largest International Textile and Garment Expo in Vietnam
ANN ARBOR, Mich., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), the biotechnology company focused on the development and commercializatio...
Kraig Biocraft Laboratories Releases First Behind the Scenes Look into the Production of Recombinant Spider Silk
ANN ARBOR, Mich., July 20, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), the biotechnology company focused on the development and commercializatio...
Kraig Biocraft Laboratories Enters Next Phase of Business Plan, Signs Deal with Contract Manufacturer to Produce Metr...
ANN ARBOR, Mich., July 18, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), the biotechnology company focused on the development and commercializatio...
Kraig Biocraft Laboratories Introduces New, Enhanced Line of Dragon Silk™ Silkworms for Commercial Production
ANN ARBOR, Mich., July 06, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), the biotechnology company focused on the development and commercializatio...
Kraig Biocraft Laboratories Takes Next Step in Launching Spydasilk™ Apparel Brand
ANN ARBOR, Mich., June 27, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), the biotechnology company focused on the development and commercializatio...
Kraig Biocraft Laboratories Subcontractor Pilot Production has achieved required Spider Silk Production Levels for th...
Kraig Labs Launches the Critical Next Phases of its Business Plan, Expanded Recombinant Spider Silk Production in Collaboration with Third-Party Contractors Kraig Labs Launches the Critical Next Phases ...
Senior Kraig Biocraft Laboratories Leaders Travel to Vietnam for High-level Meetings and Fiber Production Initiatives
Management's crowded Agenda includes meetings with Governmental Officials and intensive Factory Team Training Management's crowded Agenda includes meetings with Governmental Officials and intensive Fact...
Kraig Biocraft Laboratories Enters Biomedical Field with First Sample Shipments of Fibers and Fabrics for Tissue Engi...
ANN ARBOR, Mich., May 17, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), the biotechnology company focused on the development and commercialization...
Kraig Biocraft Laboratories Strengthens Q2 Spider Silk Production Expansion with New Vendor Quality Assurance Program
ANN ARBOR, Mich., May 03, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), the biotechnology company focused on the development and commercialization...
Kraig Biocraft Laboratories Kicks Off Q2 Recombinant Spider Silk Production as Lab Increases Testing Throughput Nearl...
ANN ARBOR, Mich., April 27, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and commercializati...
Kraig Biocraft Laboratories Receives $1.5 Million in Capital Funding
Company is in its strongest financial position ever, having raised $8 million in 16 months Company is in its strongest financial position ever, having raised $8 million in 16 months
Kraig Biocraft Laboratories Collaboration Between US and Vietnam Teams Completes First 100% Genetic Screening for In-...
ANN ARBOR, Mich., March 07, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), the biotechnology company focused on the development and commercializati...
USPTO Publishes Two Key Kraig Biocraft Laboratories Patent Applications
ANN ARBOR, Mich., Feb. 16, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), the biotechnology company focused on the development and commercializatio...
Kraig Biocraft Laboratories Delivers Dragon Silk to Spydasilk Enterprises
ANN ARBOR, Mich., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), the biotechnology company focused on the development and commercializatio...
Kraig Biocraft Laboratories Closes Additional Funding Agreement
Robust financial strength positions Company to deploy Impact Capital Robust financial strength positions Company to deploy Impact Capital
Kraig Biocraft Laboratories Prepares to Ship Finished Dragon Silk Yarn From Vietnam Factory
ANN ARBOR, Mich., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), the biotechnology company focused on the development and commercializatio...
Kraig Biocraft Laboratories Receives Equipment for Onsite Testing and Screening of Transgenic Technology at Prodigy T...
Onsite testing to enable significant production expansion Onsite testing to enable significant production expansion
A Holiday Letter from Kraig Biocraft Laboratories' CEO
ANN ARBOR, Mich., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), the leading developer of spider silk-based fibers, announces today th...
Kraig Biocraft Laboratories Spider Silk Featured on BBC Earth Series
Jon Rice, COO, Interview Clips Included in the Broadcast Jon Rice, COO, Interview Clips Included in the Broadcast
Kraig Biocraft Laboratories Expands Production Footprint, Building Self Reliant Supply Chain
Prodigy Textiles building out onsite mulberry production Prodigy Textiles building out onsite mulberry production
Kraig Biocraft Laboratories Begins Production of Fourth Generation Recombinant Spider Silk Silkworms in New Productio...
ANN ARBOR, Mich., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), the leading developer of spider silk-based fibers, announces today th...
Kraig Biocraft Laboratories Resumes Work Producing Custom Spider Silk Yarns and Fabrics with Vietnam Re-opening
ANN ARBOR, Mich., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and commercializatio...
Challenge Testing of Kraig Biocraft Laboratories' Disease Resistant Silkworms Underway
Immunity enhanced silkworms provide licensing opportunities into the broader $14B1 silk industry
Kraig Biocraft Laboratories Announces Breakthrough in Creation of New Recombinant Spider Silks
Kraig Labs files provisional patent for next-generation gene-editing system Kraig Labs files provisional patent for next-generation gene-editing system